Biora Therapeutics Has Been Granted U.S. Patent Number 11,547,301 Titled “Methods For Collecting And Testing Bacteria Containing Samples From Within The Gastrointestinal Tract” – USPTO

SEALSQ Corp ("SEALSQ" or "Company") (NASDAQ:LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, announces the launch date of SEALCOIN as